clinicaltrialsarena4h
Genentech’s Itovebi combo hits overall survival endpoint in HER2- breast cancer
The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...
clinicaltrialsarena3h
ITM’s radiotherapeutic beats out standard-of-care in Phase III trial
ITM Radiopharma’s Phase III trial of its targeted radiotherapeutic for patients with Grade 1 or 2 gastroenteropancreatic ...
clinicaltrialsarena4h
Allakos cuts 75% of workforce after chronic hives trial failure
A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.
clinicaltrialsarena6h
Akero’s cirrhosis treatment shows promise in Phase IIb study
Akero Therapeutics has revealed preliminary outcomes from its Phase IIb study of EFX in individuals with compensated ...
clinicaltrialsarena11h
Roche reports positive topline outcomes from DMD treatment trial
Roche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys for ...
clinicaltrialsarena10h
Fortress doses first subject in Phase II CMV vaccine trial
Fortress Biotech, Helocyte have announced the dosing of the first subject in the trial of Triplex for individuals who are ...